4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-009017
President sold 4,000 shares at an average $12.06 ($48,220)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ma Songjiang · President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-13 | Sale : show line 1 in the form 10b5-1 | −2,000 | $11.80 | $23,600 | 2,833,260 | I |
| 2025-03-14 | Sale : show line 2 in the form 10b5-1 | −2,000 | $12.31 | $24,620 | 2,831,260 | I |
| Open-market sales · 4,000 sh · avg $12.06 · $48,220 | ||||||
Loading xslF345X05/form4.xml…